Compositions comprising the hybrid molecule in a suitable pharmaceutical carrier are also provided.
The ligation product is a hybrid molecule comprising the linker and the mature small RNA.
The invention also provides a composition comprising a hybrid molecule as described above and a pharmaceutically acceptable carrier.
In another specific embodiment, the hybrid molecule contains an internal non-peptide structure that maintains the helical character of the TAM mimic.
Sequence, unique (French : unique séquence) Selection of a monocatenary nucleic acid after formation of a hybrid molecule with a complementary strand.
The present invention also relates to a peptide encoded by the nucleic acid of the invention, a fusion molecule comprising the peptide of the invention and a composition comprising the peptide or the fusion molecule of the invention.
Sequence, unique (French : unique séquence) Selection of a monocatenary nucleic acid after formation of a hybrid molecule with a complementary strand.
Recombinant DNA is produced when genetic information from more than one organism is recombined in a laboratory process into a hybrid molecule.
The resultant hybrid molecule is converted to two different double-stranded cDNAs, a first cDNA comprising the oligo dT primer and a second cDNA lacking the oligo dT primer.
Hybrid molecule 3 ( 6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-hydroxamic acid) was proven to posses HDAC activity while maintaining RAR agonist activity.
The invention provides a process for isolating biomaterial from other materials, especially isolating nucleic acid such as DNA or RNA or hybrid molecule of DNA and RNA.
More specifically, these enzymes can synthesis c-di-AMP, c-di-GMP, and a previously undiscovered c-AMP-GMP hybrid molecule, from ATP and GTP precursors.
Elimination half-time is altered by generating a hybrid molecule of the present invention wherein the peptide ligand has binding affinity for a plasma protein.
The invention further provides for methods of making the hybrid molecules, and methods of using the hybrid molecule described above to inhibit cell surface receptor binding.
After linking trehalose to DMN in the lab, the researchers tested their hybrid molecule, called DMN-Tre, on an M. tuberculosis relative.
AEZS-108 is a targeted cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin.
AEZS-108 represents a new targeting concept in oncology using a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin.
AEZS-108 represents a new targeting concept in oncology using a cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin.
The hybrid SK molecule and its improvement are just one of the many examples of CSIR's efforts to secure IPRs.
Zoptarelin doxorubicin (AEZS-108) represents a new targeting concept in oncology using a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод